ACE Hemoglobin A1c (HbA1c) Reagent

Assay, Glycosylated Hemoglobin

ALFA WASSERMANN DIAGNOSTIC TECHNOLOGIES, LLC

The following data is part of a premarket notification filed by Alfa Wassermann Diagnostic Technologies, Llc with the FDA for Ace Hemoglobin A1c (hba1c) Reagent.

Pre-market Notification Details

Device IDK170623
510k NumberK170623
Device Name:ACE Hemoglobin A1c (HbA1c) Reagent
ClassificationAssay, Glycosylated Hemoglobin
Applicant ALFA WASSERMANN DIAGNOSTIC TECHNOLOGIES, LLC 4 Henderson Drive West Caldwell,  NJ  07006
ContactBarbara Phillips
CorrespondentBarbara Phillips
ALFA WASSERMANN DIAGNOSTIC TECHNOLOGIES, LLC 4 Henderson Drive West Caldwell,  NJ  07006
Product CodeLCP  
CFR Regulation Number864.7470 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2017-03-01
Decision Date2018-02-27

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00857969006617 K170623 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.